{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 443536496
| IUPAC_name = 5,7-Dibromoquinolin-8-ol
| image = Broxyquinoline.png
| alt = Skeletal formula of broxyquinoline
| width = 145
| image2 = Broxyquinoline 3D ball.png
| alt2 = Ball-and-stick model of the broxyquinoline molecule
| width2 = 160

<!--Clinical data-->
| tradename =  
| Drugs.com = {{drugs.com|international|broxyquinoline}}
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category =  
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = <!--             / Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL         / P       / POM / CD / Class A, B, C -->
| legal_US = <!-- OTC                   / Rx-only  / Schedule I, II, III, IV, V -->
| legal_status =  
| routes_of_administration =  

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =  

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 521-74-4
| ATC_prefix = A07
| ATC_suffix = AX01
| ATC_supplemental = {{ATC|G01|AC06}} {{ATC|P01|AA01}}
| PubChem = 2453
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =  
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 223448
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = UK4C618C8T
|  ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = 2359
|  smiles = Brc1c(O)c2ncccc2c(Br)c1
|  StdInChI_Ref = {{stdinchicite|changed|chemspider}}
| StdInChI = 1S/C9H5Br2NO/c10-6-4-7(11)9(13)8-5(6)2-1-3-12-8/h1-4,13H
|  StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}
| StdInChIKey = ZDASUJMDVPTNTF-UHFFFAOYSA-N

<!--Chemical data-->
| C=9 | H=5 | Br=2 | N=1 | O=1 
| molecular_weight = 302.95 g/mol
}}

'''Broxyquinoline''' is an [[antiprotozoal]] agent.

An association with [[exercise intolerance]] has been reported.<ref name="pmid3081430">{{cite journal |author=Swain R, Bapna JS |title=Impairment of exercise tolerance due to broxyquinoline-brobenzoxaldine combination |journal=Hum Toxicol |volume=5 |issue=1 |pages=63â€“4 |date=January 1986 |pmid=3081430 |doi= 10.1177/096032718600500115|url=}}</ref>

==References==
{{reflist}}

{{Antidiarrheals, intestinal anti-inflammatory/anti-infective agents}}
{{Agents against amoebozoa}}

[[Category:Quinolinols]]
[[Category:Bromoarenes]]
[[Category:Antiprotozoal agents]]


{{gastrointestinal-drug-stub}}
{{antiinfective-drug-stub}}